Company: PACB
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001299130-25-000168
Chunk: 38

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 38
---
5 Form 10-Q25

A summary of the segment profit or loss, including significant segment expenses is as follows:Three Months Ended September 30,Nine Months Ended September 30,(In thousands)2025202420252024Total revenue38,441 39,967 115,360 114,790 Less:Cost of revenue22,540 29,963 86,146 87,566 Research and development22,846 25,516 74,428 107,456 Sales and marketing15,465 18,435 55,057 64,779 General and administrative15,634 25,311 52,385 68,597 Impairment charges— — 15,000 93,200 Change in fair value of contingent consideration— 1,170 (18,700)1,100 Amortization of acquired intangible assets833 3,649 363,708 13,377 Other income, net1,260 3,352 6,775 9,063 Income tax provision383 — 116 — Consolidated net loss(38,000)(60,725)(506,005)(312,222)A summary of our revenue by geographic location is as follows:Three Months Ended September 30,Nine Months Ended September 30,(In thousands)2025202420252024Americas$18,097 $20,107 $52,087 $58,542 Europe, Middle East and Africa10,752 9,119 29,459 24,497 Asia-Pacific9,592 10,741 33,814 31,751 Total revenue$38,441 $39,967 $115,360 $114,790 A summary of our revenue by category is as follows:   Three Months Ended September 30,Nine Months Ended September 30,(In thousands)2025202420252024Instrument revenue$11,318 $16,788 $36,484 $50,491 Consumable revenue21,279 18,508 60,309 51,560 Product revenue32,597 35,296 96,793 102,051 Service and other revenue5,844 4,671 18,567 12,739 Total revenue$38,441 $39,967 $115,360 $114,790